Biblio

Filters: Author is Grimm, Fabian A [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

T

Blanchette AD, Grimm FA, Dalaijamts C, Hsieh N-H, Ferguson K, Luo Y-S, Rusyn I, Chiu WA. Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships. Clin Pharmacol Ther. 2018.

P

Burnett SD, Blanchette AD, Grimm FA, House JS, Reif DM, Wright FA, Chiu WA, Rusyn I. Population-based toxicity screening in human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019:114711.

M

Grimm FA, House JS, Wilson MR, Sirenko O, Iwata Y, Wright FA, Ball N, Rusyn I. Multi-dimensional in vitro bioactivity profiling for grouping of glycol ethers. Regul Toxicol Pharmacol. 2018.

I

Cordova AC, Klaren WD, Ford LC, Grimm FA, Baker ES, Zhou Y-H, Wright FA, Rusyn I. Integrative Chemical-Biological Grouping of Complex High Production Volume Substances from Lower Olefin Manufacturing Streams. Toxics. 2023;11(7).

G

House JS, Grimm FA, Klaren WD, Dalzell A, Kuchi S, Zhang S-D, Lenz K, Boogaard PJ, Ketelslegers HB, Gant TW, et al. Grouping of UVCB substances with new approach methodologies (NAMs) data. ALTEX. 2020.

C

Grimm FA, Klaren WD, Li X, Lehmler H-J, Karmakar M, Robertson LW, Chiu WA, Rusyn I. Cardiovascular Effects of Polychlorinated Biphenyls and Their Major Metabolites. Environ Health Perspect. 2020;128(7):77008.